| Glaxo |
1988 |
Lyme
disease |
| Ciba-Geigy |
1988
|
Hypertension
|
| Eli Lilly |
1988
|
Hypertension
|
| Squibb |
1988-1989
|
Acute
bronchitis |
| G.D. Searle |
1988-1989 |
Generalized
anxiety |
| Eli Lilly |
1988-1989
|
Analgesic
(phase I, II) |
| UpJohn |
1989
|
Streptococcal
pharyngitis Uncomplicated urinary tract infection Wound and
soft tissue infection |
| LymeProject |
1997-2000
|
Lyme
Disease Surveillance Database |
| Pfizer |
2002-3 |
Gemini
study Clinical Utility study for Cholesterol and Hypertension
Phase IIIb Open labeled, multicenter trial |
| Columbia |
2001-present |
Subinvestigator
NIH sponsered trial - Columbia |
| LymeProject |
1997-present
|
Seropositive
Lyme Disease Retreatment Study |
| LymeProject |
2003-present
|
Validation of Lyme treatment (VOLT) |
| Merck |
2003 |
Migraine Therapy Evaluation Protocol Muli-center, open-label,
crossover study comparing Maxalt with usual care oral migraine
medication |
| Genzyme |
2004 |
REACH Program
An International Prosopective Observational Observational Registry
in Subjects at Risk Of Atherosthrombotic Events |
| Watson |
2004 |
MATRIX Trial
Multicenter Assessment of Transdermal Therapy in Overactive
Bladder with Oxybutynin TDS |
